Key terms

About HCAT

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HCAT news

May 01 5:14am ET Analysts’ Top Healthcare Picks: Health Catalyst (HCAT), Sartorius (GB:0NIQ) Mar 05 6:06am ET Buy Rating on Health Catalyst: Strategic Innovation and Client Growth Poised to Drive Performance Mar 05 3:15am ET Barclays Issues a Buy Rating on Health Catalyst (HCAT) Feb 26 7:36am ET RBC Capital Remains a Hold on Health Catalyst (HCAT) Feb 26 6:35am ET Maintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth Forecast Feb 23 8:29am ET Health Catalyst price target lowered to $15 from $17 at Piper Sandler Feb 23 7:49am ET Optimistic Outlook: Health Catalyst’s Growth and Profitability Potential Affirm Buy Rating Feb 23 7:33am ET Stifel Nicolaus Remains a Hold on Health Catalyst (HCAT) Feb 23 7:33am ET Piper Sandler Sticks to Their Buy Rating for Health Catalyst (HCAT) Feb 23 7:17am ET Health Catalyst price target lowered to $11 from $12 at Canaccord Feb 23 3:05am ET Health Catalyst (HCAT) Receives a Buy from Barclays Feb 22 4:33pm ET Health Catalyst Executive Team Undergoes Major Reshuffle Feb 22 4:09pm ET Health Catalyst reports Q4 adjusted EPS 2c, consensus 0c Feb 21 8:30am ET Health Catalyst’s Abe Health Registry receives QPP approval Feb 15 3:20am ET Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Regeneron (REGN) and Merck & Company (MRK) Feb 07 8:41am ET Stifel Nicolaus Sticks to Its Hold Rating for Health Catalyst (HCAT)

No recent press releases are available for HCAT

HCAT Financials

1-year income & revenue

Key terms

HCAT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HCAT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms